Selected research
Industry Research
Glycomacropeptide (GMP) Supplements Industry Research Report 2026
Market perspective
The global Glycomacropeptide (GMP) Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glycomacropeptide (GMP) Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glycomacropeptide (GMP) Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glycomacropeptide (GMP) Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glycomacropeptide (GMP) Supplements include Right Food, Nestlé Health Science, MET-Rx Nutrition Inc, Glanbia, Plc., Benfatto Nutrition, Arla Foods, AMCO Proteins and Agropur Coopérative, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glycomacropeptide (GMP) Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycomacropeptide (GMP) Supplements Market by Company
Right Food
Nestlé Health Science
MET-Rx Nutrition Inc
Glanbia, Plc.
Benfatto Nutrition
Arla Foods
AMCO Proteins
Agropur Coopérative
Glycomacropeptide (GMP) Supplements Segment by Type
Glycomacropeptide Supplements For Adults
Glycomacropeptide Supplements For Children
Glycomacropeptide (GMP) Supplements Segment by Application
Hypermarket/Supermarket
Online Stores
Medical Stores
Specialty Stores
Other
Glycomacropeptide (GMP) Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomacropeptide (GMP) Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycomacropeptide (GMP) Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomacropeptide (GMP) Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glycomacropeptide (GMP) Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glycomacropeptide (GMP) Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glycomacropeptide (GMP) Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glycomacropeptide Supplements For Adults
- Glycomacropeptide Supplements For Children
Applications
- Hypermarket/Supermarket
- Online Stores
- Medical Stores
- Specialty Stores
- Other
Companies covered
- Right Food
- Nestlé Health Science
- MET-Rx Nutrition Inc
- Glanbia, Plc.
- Benfatto Nutrition
- Arla Foods
- AMCO Proteins
- Agropur Coopérative
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glycomacropeptide (GMP) Supplements Market Size (2021-2032)
- 2.2.2 Global Glycomacropeptide (GMP) Supplements Sales (2021-2032)
- 2.2.3 Global Glycomacropeptide (GMP) Supplements Market Average Price (2021-2032)
- 2.3 Glycomacropeptide (GMP) Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glycomacropeptide Supplements For Adults
- 2.3.3 Glycomacropeptide Supplements For Children
- 2.4 Glycomacropeptide (GMP) Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hypermarket/Supermarket
- 2.4.3 Online Stores
- 2.4.4 Medical Stores
- 2.4.5 Specialty Stores
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glycomacropeptide (GMP) Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glycomacropeptide (GMP) Supplements Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Glycomacropeptide (GMP) Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Glycomacropeptide (GMP) Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Glycomacropeptide (GMP) Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glycomacropeptide (GMP) Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glycomacropeptide (GMP) Supplements, Product Type & Application
- 3.8 Global Manufacturers of Glycomacropeptide (GMP) Supplements, Established Date
- 3.9 Global Glycomacropeptide (GMP) Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Right Food
- 4.1.1 Right Food Company Information
- 4.1.2 Right Food Business Overview
- 4.1.3 Right Food Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Right Food Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.1.5 Right Food Recent Developments
- 4.2 Nestlé Health Science
- 4.2.1 Nestlé Health Science Company Information
- 4.2.2 Nestlé Health Science Business Overview
- 4.2.3 Nestlé Health Science Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nestlé Health Science Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.2.5 Nestlé Health Science Recent Developments
- 4.3 MET-Rx Nutrition Inc
- 4.3.1 MET-Rx Nutrition Inc Company Information
- 4.3.2 MET-Rx Nutrition Inc Business Overview
- 4.3.3 MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.3.5 MET-Rx Nutrition Inc Recent Developments
- 4.4 Glanbia, Plc.
- 4.4.1 Glanbia, Plc. Company Information
- 4.4.2 Glanbia, Plc. Business Overview
- 4.4.3 Glanbia, Plc. Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glanbia, Plc. Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.4.5 Glanbia, Plc. Recent Developments
- 4.5 Benfatto Nutrition
- 4.5.1 Benfatto Nutrition Company Information
- 4.5.2 Benfatto Nutrition Business Overview
- 4.5.3 Benfatto Nutrition Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Benfatto Nutrition Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.5.5 Benfatto Nutrition Recent Developments
- 4.6 Arla Foods
- 4.6.1 Arla Foods Company Information
- 4.6.2 Arla Foods Business Overview
- 4.6.3 Arla Foods Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Arla Foods Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.6.5 Arla Foods Recent Developments
- 4.7 AMCO Proteins
- 4.7.1 AMCO Proteins Company Information
- 4.7.2 AMCO Proteins Business Overview
- 4.7.3 AMCO Proteins Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AMCO Proteins Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.7.5 AMCO Proteins Recent Developments
- 4.8 Agropur Coopérative
- 4.8.1 Agropur Coopérative Company Information
- 4.8.2 Agropur Coopérative Business Overview
- 4.8.3 Agropur Coopérative Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Agropur Coopérative Glycomacropeptide (GMP) Supplements Product Portfolio
- 4.8.5 Agropur Coopérative Recent Developments
5 Global Glycomacropeptide (GMP) Supplements Market Scenario by Region
- 5.1 Global Glycomacropeptide (GMP) Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glycomacropeptide (GMP) Supplements Sales by Region: 2021-2032
- 5.2.1 Global Glycomacropeptide (GMP) Supplements Sales by Region: 2021-2026
- 5.2.2 Global Glycomacropeptide (GMP) Supplements Sales by Region: 2027-2032
- 5.3 Global Glycomacropeptide (GMP) Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Glycomacropeptide (GMP) Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Glycomacropeptide (GMP) Supplements Revenue by Region: 2027-2032
- 5.4 North America Glycomacropeptide (GMP) Supplements Market Facts & Figures by Country
- 5.4.1 North America Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2032)
- 5.4.3 North America Glycomacropeptide (GMP) Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Glycomacropeptide (GMP) Supplements Market Facts & Figures by Country
- 5.5.1 Europe Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glycomacropeptide (GMP) Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Glycomacropeptide (GMP) Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Glycomacropeptide (GMP) Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glycomacropeptide (GMP) Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glycomacropeptide (GMP) Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glycomacropeptide (GMP) Supplements Market Facts & Figures by Country
- 5.7.1 South America Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2032)
- 5.7.3 South America Glycomacropeptide (GMP) Supplements Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glycomacropeptide (GMP) Supplements Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Glycomacropeptide (GMP) Supplements Sales by Type (2021-2032)
- 6.1.1 Global Glycomacropeptide (GMP) Supplements Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Glycomacropeptide (GMP) Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Glycomacropeptide (GMP) Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Glycomacropeptide (GMP) Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glycomacropeptide (GMP) Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Glycomacropeptide (GMP) Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glycomacropeptide (GMP) Supplements Sales by Application (2021-2032)
- 7.1.1 Global Glycomacropeptide (GMP) Supplements Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Glycomacropeptide (GMP) Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Glycomacropeptide (GMP) Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Glycomacropeptide (GMP) Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glycomacropeptide (GMP) Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Glycomacropeptide (GMP) Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glycomacropeptide (GMP) Supplements Value Chain Analysis
- 8.1.1 Glycomacropeptide (GMP) Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glycomacropeptide (GMP) Supplements Production Mode & Process
- 8.2 Glycomacropeptide (GMP) Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glycomacropeptide (GMP) Supplements Distributors
- 8.2.3 Glycomacropeptide (GMP) Supplements Customers
9 Global Glycomacropeptide (GMP) Supplements Analyzing Market Dynamics
- 9.1 Glycomacropeptide (GMP) Supplements Industry Trends
- 9.2 Glycomacropeptide (GMP) Supplements Industry Drivers
- 9.3 Glycomacropeptide (GMP) Supplements Industry Opportunities and Challenges
- 9.4 Glycomacropeptide (GMP) Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst